Saundra S Buys

发表

The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer

Norman Boyd, John L Hopper, Irene L Andrulis, 2004, Breast Cancer Research.

The macrophage stimulating protein/Ron pathway as a potential therapeutic target to impede multiple mechanisms involved in breast cancer progression.

S. Buys, A. Welm, Saundra S Buys, 2010, Current drug targets.

Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay

Zhiyuan Hu, Nicholas P Gauthier, Charles M Perou, 2006, Breast Cancer Research.

Integrative analyses reveal signaling pathways underlying familial breast cancer susceptibility

Stephen R. Piccolo, Irene L Andrulis, William Evan Johnson, 2016, Molecular systems biology.

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.

Christiana Kartsonaki, Mads Thomassen, Etienne Rouleau, 2011, Human molecular genetics.

Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.

Mads Thomassen, Nina Ditsch, Dieter Niederacher, 2009, Human molecular genetics.

Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.

Kenneth Offit, Elizabeth Swisher, Seema Khan, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.

Dong Liang, Patrick Neven, Harvey Risch, 2016, Journal of the National Cancer Institute.

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population

Christiana Kartsonaki, Mads Thomassen, Julian Peto, 2010, Nature Genetics.

Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort

Robert N Hoover, James V Lacey, P. Prorok, 2009, BMC Cancer.

Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

David A Lynch, John K Gohagan, Carl R Fuhrman, 2010, Journal of the National Cancer Institute.

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

Mads Thomassen, Nina Ditsch, Muhammad Usman Rashid, 2015, JAMA.

Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.

Mark P Purdue, Barnett S Kramer, John K Gohagan, 2012, The New England journal of medicine.

Breast-cancer risk in families with mutations in PALB2.

Nazneen Rahman, Katri Pylkäs, Arto Mannermaa, 2014, The New England journal of medicine.

Combating subclonal evolution of resistant cancer phenotypes

Brent S. Pedersen, Gabor Marth, Ryan M. Layer, 2017, Nature Communications.

Mortality results from a randomized prostate-cancer screening trial.

David Chia, Timothy R Church, Barnett S Kramer, 2009, The New England journal of medicine.

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

Mads Thomassen, Etienne Rouleau, Dieter Niederacher, 2010, Cancer research.

Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial.

David Chia, John K Gohagan, Christine C Johnson, 2005, American journal of obstetrics and gynecology.

Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management Tool

Jack Cuzick, Gord Glendon, Mary Beth Terry, 2019, JNCI cancer spectrum.

Results From Four Rounds of Ovarian Cancer Screening in a Randomized Trial

Timothy R Church, Christine C Johnson, Edward Partridge, 2009, Obstetrics and gynecology.

Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes

Mark T. W. Ebbert, L. Neumayer, I. Stijleman, 2011, Nature Medicine.

10-year performance of four models of breast cancer risk: a validation study.

Gord Glendon, Mary Beth Terry, John L Hopper, 2019, The Lancet. Oncology.

Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness.

Stefania Tommasi, Laura Cortesi, Mads Thomassen, 2019, Cancer research.